Andrew Ip

Andrew Ip, MD

Hackensack Meridian Health

Moderator

Financial Disclosure

Graticule (relationship ended as of 08/2024

Consultant

Deciphera/ONO (Institutional Research Support)

Researcher

Genmab (Institutional Research Support)

Researcher

Gilead/Kite (Institutional Research Support)

Researcher

Leuko Labs (Institutional Research Support)

Researcher

Lyell (Institutional Research Support)

Researcher

BeiGene (Institutional Research Support) ended as of 02/2025

Researcher

COTA (Cancer Outcomes Tracking & Analytics) cotahealthcare.com

Ownership Interest

Cullinan (Institutional Research Support) ended as of 08/2024

Researcher

AbbVie (relationship ended as of 12/2024

Consultant

AbbVie (relationship ended as of 2/2025)

Speaker

Outcomes Matters, Innovation (OMI)

Ownership Interest